Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $75000.0.

  • Treace Medical Concepts' Amortization of Deferred Charges rose 135.14% to $75000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $298000.0, marking a year-over-year increase of 33.67%. This contributed to the annual value of $298000.0 for FY2024, which is 33.67% up from last year.
  • Latest data reveals that Treace Medical Concepts reported Amortization of Deferred Charges of $75000.0 as of Q3 2025, which was up 135.14% from $74000.0 recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Amortization of Deferred Charges registered a high of $75000.0 during Q4 2022, and its lowest value of $43000.0 during Q1 2021.
  • Over the past 5 years, Treace Medical Concepts' median Amortization of Deferred Charges value was $74000.0 (recorded in 2022), while the average stood at $65157.9.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first plummeted by 3384.62% in 2021, then soared by 7441.86% in 2022.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Amortization of Deferred Charges stood at $43000.0 in 2021, then surged by 74.42% to $75000.0 in 2022, then dropped by 1.33% to $74000.0 in 2023, then increased by 1.35% to $75000.0 in 2024, then changed by 0.0% to $75000.0 in 2025.
  • Its Amortization of Deferred Charges stands at $75000.0 for Q3 2025, versus $74000.0 for Q2 2025 and $74000.0 for Q1 2025.